This program consists of one-hour podcast episodes where we interview top AML researchers on their open clinical trials and other key AML news topics.
Each article will include background information on the AML researcher, a summary of the radio show, the full radio recording so you can listen to the entire show whenever you want, and a written transcript in case you would rather read the interview.
This podcast is great for AML patients who are interested in learning about the most cutting-edge AML research. These shows go beyond the basic question of "what is AML" and really explain all the ins and outs of AML in great detail. By listening, you are able to learn about which AML research trials you may be able to participate in. Be on the lookout for announcements on our upcoming episodes so that you can mark your calendar and listen live!
HealthTree Podcast for AML—June 23, 2022
Join us on June 29th at 2 pm EST to hear from Dr. Jane Liesveld from the University of Rochester about FLT3 inhibitor drugs available and in development.
HealthTree Podcast for AML—June 9, 2022
Listen to the full recording of our conversation with Dr. Kendra Sweet, an AML expert, about a new antibody drug conjugate in development called IMGN632.
HealthTree Podcast for AML—May 26, 2022
Listen to the full recording of our conversation with Dr. Joseph Jurcic, an AML expert, about a new immunotherapy drug in development called magrolimab.
HealthTree Podcast for AML—February 28, 2022
Listen to the full recording (or read the transcript) of our conversation with Dr. Margaret Kasner, an AML expert from Sidney Kimmel Cancer Center as she summarizes key developments and clinical trials currently underway for FLT3 positive AML.
HealthTree Podcast for AML—February 18, 2022
Listen to the full recording (or read the transcript) of our conversation with Dr. Eytan Stein, an AML expert from Memorial Sloan Kettering Cancer Center as he shares his top abstracts of 2021 that were presented by himself and his AML colleagues at the 2021 ASH conference and provides us his thoughts on what AML advancements and research to look out for in 2022.
HealthTree Podcast for AML—October 25, 2021
Listen to the full recording of our conversation with Dr. James Blachly, an AML expert from Ohio State University as he provides a comprehensive overview of newer AML treatments and discusses their use in clinics and hospitals today. Additionally, he shares an overview of the promising agents currently under development along with information on key clinical trials taking place that will further shape the future of AML treatment.
HealthTree Podcast for AML—October 1, 2021
Listen to the full recording of our conversation with Dr. John Reagan, an AML expert from the Lifespan Cancer Institute at Rhode Island Hospital as he discusses relapsed and refractory AML. He reviews how immunotherapy is a promising area of AML research and discusses his open clinical trial looking at the combination of gemtuzumab and donor leukocyte infusion.
HealthTree Podcast for AML—September 20, 2021
Listen to the full recording of our conversation with Dr. Gabriel Mannis, an AML expert from the Stanford Cancer Institute in California about how hypomethylating agents and venetoclax have become the new standard of care for older individuals with AML and his open clinical trial looking at what could become the first all oral therapy for newly diagnosed AML.
HealthTree Podcast for AML—August 26, 2021
Announcing HealthTree for AML Radio, a podcast style series of interviews with top AML experts about their open clinical trials! Join us for our first radio show on 9/13 with Dr. Mannis of the Stanford Cancer Center to learn about treatment options for older adults and his open trial evaluating what could be the first all oral therapy for newly diagnosed older adults with AML.